Neutrogena Apologizes for Past Treatment of Hayden Panettiere Amid Backlash

Key points

• Neutrogena responded to widespread boycott calls by stating it 'made her feel unsupported during a very difficult time' and that this behavior does not align with its values.
• The company pledged to make a 'significant investment' in a community health partner to improve access to postpartum depression care for women.
• Panettiere, who served as a brand ambassador from 2005 to 2015, claimed in her memoir and podcast interviews that Neutrogena invoked a morals clause to end their deal after she discussed her struggles on television.
• The brand delayed its statement until August 21, 2026, citing respect for Panettiere's family following her death on August 16, 2026, which remains under investigation with pending autopsy results.
• Fans and social media users criticized the brand's historical handling of the situation, leading to a surge in negative comments and boycott campaigns across platforms like Instagram and TikTok.

Background

This incident resurfaces a long-standing controversy regarding corporate support for mental health disclosures. Previous coverage noted that Panettiere's claims about being fired for discussing postpartum depression had circulated since her 2015 interview but gained massive traction only after her recent passing. The brand's delayed response reflects a strategic decision to prioritize mourning over immediate crisis management, a tactic that has been scrutinized in similar corporate PR scenarios.

How outlets are covering it

The Daily Beast emphasizes the timeline of the backlash, noting that the controversy reignited immediately after Panettiere's death and that the brand's silence initially fueled anger. NBC News focuses on the specific language of the apology, highlighting the brand's admission that it 'made her feel unsupported' and its concrete pledge to fund mental health resources. While both outlets confirm the core facts of the 2015 contract termination and the 2026 apology, NBC News provides more detail on Panettiere's personal account of the event, including her representative's claim that the termination was illegal, whereas The Daily Beast focuses more on the public reaction and the brand's ownership by Kenvue.

Why it matters

This case highlights the growing public scrutiny of corporate partnerships with celebrities, particularly regarding mental health advocacy. The backlash demonstrates that consumers are increasingly holding brands accountable for past actions, even years later, and that silence during a crisis can exacerbate reputational damage. The pledge to invest in postpartum care signals a shift toward more substantive corporate social responsibility in the beauty industry.

What to watch

The investigation into Panettiere's cause of death is ongoing, with the coroner's office pending further results. Neutrogena is expected to detail the specifics of its new investment in postpartum depression resources in the coming weeks. The brand may also face continued scrutiny from consumers and advocacy groups regarding its historical treatment of mental health disclosures in celebrity contracts.